08:07 AM EDT, 03/10/2025 (MT Newswires) -- NeoGenomics ( NEO ) said Friday that it has acquired Pathline, a New Jersey-based laboratory, to strengthen its commercial presence in the Northeast US, expand service capabilities, and accelerate growth in molecular and hematology-oncology testing.

The company said it expects the deal to be accretive to adjusted Ebitda starting next year.

Financial details of the deal were not disclosed.